"Designing Growth Strategies is in our DNA"

Infectious Disease Point-of-care (POC) Diagnostics Market Size, Share & COVID-19 Impact Analysis, By Technique (Lateral Flow Immunoassay, Agglutination Test), By Disease (HIV, Hepatitis B Virus, Respiratory Syncytial Virus, Influenza, Clostridium Difficile Infections), By Disease, COVID-19 Point-of-care (POC) Diagnostics, By End User (Hospital Bedside, Physicians Office Lab, Urgent Care & Retail Clinics), Regional Forecast, 2021-2028

Region : Global | Format: PDF | Report ID: FBI104307

 

Table of Content:

  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Key Infectious Diseases, By Key Countries
    2. New Product Launches
    3. Key Industrial Developments (Mergers, Acquisitions, Partnerships, etc.)
    4. Technological Advancements in Infectious Disease Point-of-care (POC) Diagnostics
    5. Impact of COVID-19 on Infectious Disease Point-of-care (POC) Diagnostics Market
    6. Overview of Initiatives for Infectious Disease Point-of-care (POC) Diagnostics in Emerging Countries
    7. Pricing Analysis of Various Infectious Disease Point-of-care (POC) Diagnostics, By Key Companies
    8. Analysis of Product Features of Key Infectious Disease Point-of-care (POC) Diagnostics, By Key Companies
  5. Global Infectious Disease Point-of-care (POC) Diagnostics Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Technique
      1. Lateral Flow Immunoassay (LFIA)
      2. Agglutination Tests
      3. Flow-through Tests / Immunoconcentration Assays
      4. Molecular Diagnostics
      5. Others
    3. Market Analysis, Insights and Forecast – By Disease
      1. Human Immunodeficiency Virus (HIV)
      2. Hepatitis B Virus (HBV)
      3. Pneumonia / Streptococcus Associated Infections
      4. Respiratory Syncytial Virus (RSV)
      5. Influenza
      6. Clostridium difficile infection (CDI)
      7. Hepatitis C Virus (HCV)
      8. Methicillin-Resistant Staphylococcus Aureus (MRSA)
      9. Tuberculosis (TB)
      10. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospital Bedside
      2. Physician's Office Lab
      3. Urgent Care & Retail Clinics
      4. Home & Self-Testing
      5. Nursing Homes
      6. Others
    5. Market Analysis, Insights and Forecast – By Geography
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Infectious Disease Point-of-care (POC) Diagnostics Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Technique
      1. Lateral Flow Immunoassay (LFIA)
      2. Agglutination Tests
      3. Flow-through Tests / Immunoconcentration Assays
      4. Molecular Diagnostics
      5. Others
    3. Market Analysis, Insights and Forecast – By Disease
      1. Human Immunodeficiency Virus (HIV)
      2. Hepatitis B Virus (HBV)
      3. Pneumonia / Streptococcus Associated Infections
      4. Respiratory Syncytial Virus (RSV)
      5. Influenza
      6. Clostridium difficile infection (CDI)
      7. Hepatitis C Virus (HCV)
      8. Methicillin-Resistant Staphylococcus Aureus (MRSA)
      9. Tuberculosis (TB)
      10. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospital Bedside
      2. Physician's Office Lab
      3. Urgent Care & Retail Clinics
      4. Home & Self-Testing
      5. Nursing Homes
      6. Others
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Infectious Disease Point-of-care (POC) Diagnostics Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Technique
      1. Lateral Flow Immunoassay (LFIA)
      2. Agglutination Tests
      3. Flow-through Tests / Immunoconcentration Assays
      4. Molecular Diagnostics
      5. Others
    3. Market Analysis, Insights and Forecast – By Disease
      1. Human Immunodeficiency Virus (HIV)
      2. Hepatitis B Virus (HBV)
      3. Pneumonia / Streptococcus Associated Infections
      4. Respiratory Syncytial Virus (RSV)
      5. Influenza
      6. Clostridium difficile infection (CDI)
      7. Hepatitis C Virus (HCV)
      8. Methicillin-Resistant Staphylococcus Aureus (MRSA)
      9. Tuberculosis (TB)
      10. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospital Bedside
      2. Physician's Office Lab
      3. Urgent Care & Retail Clinics
      4. Home & Self-Testing
      5. Nursing Homes
      6. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Infectious Disease Point-of-care (POC) Diagnostics Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Technique
      1. Lateral Flow Immunoassay (LFIA)
      2. Agglutination Tests
      3. Flow-through Tests / Immunoconcentration Assays
      4. Molecular Diagnostics
      5. Others
    3. Market Analysis, Insights and Forecast – By Disease
      1. Human Immunodeficiency Virus (HIV)
      2. Hepatitis B Virus (HBV)
      3. Pneumonia / Streptococcus Associated Infections
      4. Respiratory Syncytial Virus (RSV)
      5. Influenza
      6. Clostridium difficile infection (CDI)
      7. Hepatitis C Virus (HCV)
      8. Methicillin-Resistant Staphylococcus Aureus (MRSA)
      9. Tuberculosis (TB)
      10. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospital Bedside
      2. Physician's Office Lab
      3. Urgent Care & Retail Clinics
      4. Home & Self-Testing
      5. Nursing Homes
      6. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Infectious Disease Point-of-care (POC) Diagnostics Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Technique
      1. Lateral Flow Immunoassay (LFIA)
      2. Agglutination Tests
      3. Flow-through Tests / Immunoconcentration Assays
      4. Molecular Diagnostics
      5. Others
    3. Market Analysis, Insights and Forecast – By Disease
      1. Human Immunodeficiency Virus (HIV)
      2. Hepatitis B Virus (HBV)
      3. Pneumonia / Streptococcus Associated Infections
      4. Respiratory Syncytial Virus (RSV)
      5. Influenza
      6. Clostridium difficile infection (CDI)
      7. Hepatitis C Virus (HCV)
      8. Methicillin-Resistant Staphylococcus Aureus (MRSA)
      9. Tuberculosis (TB)
      10. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospital Bedside
      2. Physician's Office Lab
      3. Urgent Care & Retail Clinics
      4. Home & Self-Testing
      5. Nursing Homes
      6. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Infectious Disease Point-of-care (POC) Diagnostics Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Technique
      1. Lateral Flow Immunoassay (LFIA)
      2. Agglutination Tests
      3. Flow-through Tests / Immunoconcentration Assays
      4. Molecular Diagnostics
      5. Others
    3. Market Analysis, Insights and Forecast – By Disease
      1. Human Immunodeficiency Virus (HIV)
      2. Hepatitis B Virus (HBV)
      3. Pneumonia / Streptococcus Associated Infections
      4. Respiratory Syncytial Virus (RSV)
      5. Influenza
      6. Clostridium difficile infection (CDI)
      7. Hepatitis C Virus (HCV)
      8. Methicillin-Resistant Staphylococcus Aureus (MRSA)
      9. Tuberculosis (TB)
      10. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospital Bedside
      2. Physician's Office Lab
      3. Urgent Care & Retail Clinics
      4. Home & Self-Testing
      5. Nursing Homes
      6. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. By Disease, COVID-19 Point of care (POC) Diagnostics Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Technique
      1. Lateral Flow Immunoassay (LFIA)
      2. Agglutination Tests
      3. Flow-through Tests / Immunoconcentration Assays
      4. Molecular Diagnostics
      5. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospital Bedside
      2. Physician's Office Lab
      3. Urgent Care & Retail Clinics
      4. Home & Self-Testing
      5. Nursing Homes
      6. Others
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  12. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2020)
    3. Company Profiles (Overview, Product Types & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Thermo Fisher Scientific Inc.
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. Quest Diagnostics Incorporated
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. BD
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. bioMérieux SA
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. Cardinal Health, Inc.
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. Cepheid
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Mesa Biotech
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. Trinity Biotech
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      10. Quidel Corporation
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      11. Bio-Rad Laboratories, Inc.
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      12. Abbott Laboratories
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      13. Other Prominent Players
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
  13. Strategic Recommendations

List of Figures

Figure 01: Global Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), by Region, 2020 & 2028

Figure 02: Global Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By Technique, 2020 & 2028

Figure 03: Global Infectious Disease Point-of-care (POC) Diagnostics Market Forecast (USD Billion), By Lateral Flow Immunoassay (LFIA), 2017 -2028

Figure 04: Global Infectious Disease Point-of-care (POC) Diagnostics Market Forecast (USD Billion), By Agglutination Tests, 2017 -2028

Figure 05: Global Infectious Disease Point-of-care (POC) Diagnostics Market Forecast (USD Billion), By Flow-through Tests / Immunoconcentration Assays, 2017 -2028

Figure 06: Global Infectious Disease Point-of-care (POC) Diagnostics Market Forecast (USD Billion), By Molecular Diagnostics, 2017 -2028

Figure 07 Global Infectious Disease Point-of-care (POC) Diagnostics Market Forecast (USD Billion), By Others, 2017 -2028

Figure 08: Global Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By Disease Type, 2020 & 2028

Figure 09: Global Infectious Disease Point-of-care (POC) Diagnostics Market Forecast (USD Billion), By Human Immunodeficiency Virus (HIV) 2017 -2028

Figure 10: Global Infectious Disease Point-of-care (POC) Diagnostics Market Forecast (USD Billion), By Hepatitis B Virus (HBV) 2017 -2028

Figure 11: Global Infectious Disease Point-of-care (POC) Diagnostics Market Forecast (USD Billion), By Pneumonia / Streptococcus Associated Infections 2017 -2028

Figure 12: Global Infectious Disease Point-of-care (POC) Diagnostics Market Forecast (USD Billion), By Respiratory Syncytial Virus (RSV) 2017 -2028

Figure 13: Global Infectious Disease Point-of-care (POC) Diagnostics Market Forecast (USD Billion), By Influenza 2017 -2028

Figure 14: Global Infectious Disease Point-of-care (POC) Diagnostics Market Forecast (USD Billion), By Clostridium difficile infection (CDI) 2017 -2028

Figure 15: Global Infectious Disease Point-of-care (POC) Diagnostics Market Forecast (USD Billion), By Hepatitis C Virus (HCV) 2017 -2028

Figure 16: Global Infectious Disease Point-of-care (POC) Diagnostics Market Forecast (USD Billion), By Methicillin-Resistant Staphylococcus Aureus (MRSA) 2017 -2028

Figure 17: Global Infectious Disease Point-of-care (POC) Diagnostics Market Forecast (USD Billion), By Tuberculosis (TB) 2017 -2028

Figure 18: Global Infectious Disease Point-of-care (POC) Diagnostics Market Forecast (USD Billion), By Others 2017 -2028

Figure 19: Global Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By End User, 2020 & 2028

Figure 20: Global Infectious Disease Point-of-care (POC) Diagnostics Market Forecast (USD Billion), By Hospital Bedside, 2017 -2028

Figure 21: Global Infectious Disease Point-of-care (POC) Diagnostics Market Forecast (USD Billion), By Physician's Office Lab2017 -2028

Figure 22: Global Infectious Disease Point-of-care (POC) Diagnostics Market Forecast (USD Billion), By Urgent Care & Retail Clinics 2017 -2028

Figure 23: Global Infectious Disease Point-of-care (POC) Diagnostics Market Forecast (USD Billion), By Home & Self Testing 2017 -2028

Figure 24: Global Infectious Disease Point-of-care (POC) Diagnostics Market Forecast (USD Billion), By Nursing Homes, 2017 -2028

Figure 25: Global Infectious Disease Point-of-care (POC) Diagnostics Market Forecast (USD Billion), By Others 2017 -2028

Figure 26: North America Infectious Disease Point-of-care (POC) Diagnostics Market Value (USD Billion), By Country, 2020 & 2028

Figure 27: North America Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By Country, 2020

Figure 28: North America Infectious Disease Point-of-care (POC) Diagnostics Market Value (USD Billion), By Technique, 2020 & 2028

Figure 29: North America Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By Technique, 2020

Figure 30: North America Infectious Disease Point-of-care (POC) Diagnostics Market Value (USD Billion), By Disease Type, 2020 & 2028

Figure 31: North America Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By Disease Type, 2020

Figure 32: North America Infectious Disease Point-of-care (POC) Diagnostics Market Value (USD Billion), By End User, 2020 & 2028

Figure 33: North America Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By End User, 2020

Figure 34: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Value (USD Billion), By Country, 2020 & 2028

Figure 35: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By Country, 2020

Figure 36: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Value (USD Billion), By Technique, 2020 & 2028

Figure 37: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By Technique, 2020

Figure 38: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Value (USD Billion), By Disease Type, 2020 & 2028

Figure 39: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By Disease Type, 2020

Figure 40: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Value (USD Billion), By End User, 2020 & 2028

Figure 41: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By End User, 2020

Figure 42: Asia Pacific Infectious Disease Point-of-care (POC) Diagnostics Market Value (USD Billion), By Country, 2020 & 2028

Figure 43: Asia Pacific Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By Country, 2020

Figure 44: Asia Pacific Infectious Disease Point-of-care (POC) Diagnostics Market Value (USD Billion), By Technique, 2020 & 2028

Figure 45: Asia Pacific Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By Technique, 2020

Figure 46: Asia Pacific Infectious Disease Point-of-care (POC) Diagnostics Market Value (USD Billion), By Disease Type, 2020 & 2028

Figure 47: Asia Pacific Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By Disease Type, 2020

Figure 48: Asia Pacific Infectious Disease Point-of-care (POC) Diagnostics Market Value (USD Billion), By End User, 2020 & 2028

Figure 49: Asia Pacific Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By End User, 2020

Figure 50: Latin America Infectious Disease Point-of-care (POC) Diagnostics Market Value (USD Billion), By Country, 2020 & 2028

Figure 51: Latin America Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By Country, 2020

Figure 52: Latin America Infectious Disease Point-of-care (POC) Diagnostics Market Value (USD Billion), By Technique, 2020 & 2028

Figure 53: Latin America Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By Technique, 2020

Figure 54: Latin America Infectious Disease Point-of-care (POC) Diagnostics Market Value (USD Billion), By Disease Type, 2020 & 2028

Figure 55: Latin America Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By Disease Type, 2020

Figure 56: Latin America Infectious Disease Point-of-care (POC) Diagnostics Market Value (USD Billion), By End User, 2020 & 2028

Figure 57: Latin America Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By End User, 2020

Figure 58: Middle East & Africa Infectious Disease Point-of-care (POC) Diagnostics Market Value (USD Billion), By Country, 2020 & 2028

Figure 59: Middle East & Africa Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By Country, 2020

Figure 60: Middle East & Africa Infectious Disease Point-of-care (POC) Diagnostics Market Value (USD Billion), By Technique, 2020 & 2028

Figure 61: Middle East & Africa Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By Technique, 2020

Figure 62: Middle East & Africa Infectious Disease Point-of-care (POC) Diagnostics Market Value (USD Billion), By Disease Type, 2020 & 2028

Figure 63: Middle East & Africa Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By Disease Type, 2020

Figure 64: Middle East & Africa Infectious Disease Point-of-care (POC) Diagnostics Market Value (USD Billion), By End User, 2020 & 2028

Figure 65: Middle East & Africa Infectious Disease Point-of-care (POC) Diagnostics Market Value Share (%), By End User, 2020

Figure 66: Global COVID-19 Point of Care (POC) Diagnostics Market Value Share (%), by Region, 2020 & 2028

Figure 67: Global COVID-19 Point of Care (POC) Diagnostics Market Value Share (%), By Technique, 2020 & 2028

Figure 68: Global COVID-19 Point of Care (POC) Diagnostics Market Value Share (%), By End User, 2020 & 2028

Figure 69: Global Infectious Disease Point-of-care (POC) Diagnostics Market Share, By Company, 2020

List of Tables

Table 01: Global Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, by Region, 2017–2028

Table 02: Global Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By Technique, 2017 - 2028

Table 03: Global Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By Disease Type, 2017 - 2028

Table 04: Global Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By End User, 2017 - 2028

Table 05: North America Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By Country, 2017 -2028

Table 06: North America Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By Technique, 2017 -2028

Table 07: North America Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By Disease Type, 2017 - 2028

Table 08: North America Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By End User, 2017 - 2028

Table 09: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By Country, 2017 -2028

Table 10: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By Technique, 2017 -2028

Table 11: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By Disease Type, 2017 -2028

8able 12: Europe Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By End User, 2017 -2028

Table 13: Asia Pacific Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By Country, 2017 - 2028

Table 14: Asia Pacific Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By Technique, 2017 -2028

Table 15: Asia Pacific Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By Disease Type, 2016 -2028

Table 16: Asia Pacific Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By End User, 2017 -2028

Table 17: Latin America Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By Country, 2017 - 2028

Table 18: Latin America Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By Technique, 2017 -2028

Table 19: Latin America Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By Disease Type, 2017 -2028

Table 20: Latin America Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By End User, 2017 -2028

Table 21: Middle East & Africa Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By Country, 2017 - 2028

Table 22: Middle East & Africa Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By Technique, 2017 -2028

Table 23: Middle East & Africa Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By Disease Type, 2017 -2028

Table 24: Middle East & Africa Infectious Disease Point-of-care (POC) Diagnostics Market Revenue (USD Billion) Forecast, By End User, 2017 -2028

 class=
  • Aug, 2021
  • 2020
  • 2017-2019
  • 180

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X